CV (cardiovascular) device incubator looking to create 6 new companies - update
This article was originally published in Clinica
Up to six new companies will be created to develop cardiovascular devices under the aegis of Accelerated Technologies Inc (ATI), a New York-based medtech incubator. ATI has just raised $32m in venture financing in equal parts from venture capital firms US-based Oxford Bioscience Partners, Dutch ABN AMRO Capital and Giza Venture Capital (Israel).
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.